June 14–16, 2022
Attending – Rita N. Bárcia, PhD, VP, Process Development & Operations
It’s an exciting time if you’re focused on myeloid targets. The Tumor Myeloid-Directed Therapeutics Summit is the only industry-focused meeting dedicated to unlocking novel therapeutic potential through the myeloid compartment. Rita N. Bárcia, PhD, vice president of process development and operations here at SIRPant will be in attendance.